EMN
52
-4
DAL
80
3
BWA
42
-2
TMO
51
4
PEG
44
-2
BBY
40
2
MAS
56
-2
RF
56
-2
SE
52
2
FDX
39
-5
NKE
30
2
KIM
66
2
MCHP
41
2
COP
48
-5
NI
58
-5
SWKS
36
3
DHI
43
-2
ETR
66
-9
YUM
38
2
SWK
64
3
EMN
52
-4
DAL
80
3
BWA
42
-2
TMO
51
4
PEG
44
-2
BBY
40
2
MAS
56
-2
RF
56
-2
SE
52
2
FDX
39
-5
NKE
30
2
KIM
66
2
MCHP
41
2
COP
48
-5
NI
58
-5
SWKS
36
3
DHI
43
-2
ETR
66
-9
YUM
38
2
SWK
64
3
Financhill
Back

Credit Suisse X-Lnks Crde OlShrsCvCllETN Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
33

USOI
Credit Suisse X-Lnks Crde OlShrsCvCllETN

Last Price:
66.22
Seasonality Move:
-2.22%
Sell
35

ALNY
Alnylam Pharmaceuticals

Last Price:
269.53
Seasonality Move:
13.19%
Sell
33
Credit Suisse X-Lnks Crde OlShrsCvCllETN (USOI) is a Sell

Is Credit Suisse X-Lnks Crde OlShrsCvCllETN a Buy, Sell or Hold?

  • The current Credit Suisse X-Lnks Crde OlShrsCvCllETN [USOI] share price is $64.41. The Score for USOI is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • USOI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $273.91. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

USOI Stock Price Chart

What is Credit Suisse X-Lnks Crde OlShrsCvCllETN's stock price today?

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $273.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

USOI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.83 Sell
Relative Strength Index (14 RSI): 47.6 Sell
Chaikin Money Flow: -26235 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.3 - 67.42) Sell
Bollinger Bands (100): (66.06 - 73.44) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.53 Buy
Relative Strength Index (14 RSI): 44.14 Sell
Chaikin Money Flow: 854887 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (270.99 - 291.37) Sell
Bollinger Bands (100): (223 - 289.2) Buy

USOI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.38 Buy
20-day SMA: 65.68 Sell
50-day SMA: 66.79 Sell
200-day SMA: 72.04 Sell
8-day EMA: 64.51 Sell
20-day EMA: 65.26 Sell
50-day EMA: 66.82 Sell
200-day EMA: 71.34 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 283.39 Sell
20-day SMA: 283.12 Sell
50-day SMA: 274.41 Sell
200-day SMA: 205.7 Buy
8-day EMA: 280.46 Sell
20-day EMA: 281.6 Sell
50-day EMA: 272.95 Buy
200-day EMA: 226.73 Buy

Credit Suisse X-Lnks Crde OlShrsCvCllETN Earnings Growth & USOI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and an increase next year of $0.66 per share.

Credit Suisse X-Lnks Crde OlShrsCvCllETN Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):